RL（人非Hodgkin淋巴瘤）
CBP60269
詢 價
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. General information | |
| Synonyms: | RL |
| Background: | RL is a human non-Hodgkin's lymphoma B cell line originated in 1983 by Walter J. Urba and Dan L. Longo. |
| Species: | Homo sapiens, human |
| Tissue: | ascites |
| Disease: | non-Hodgkin's lymphoma |
| Gender: | male, 52 years, Caucasian |
| Morphology: | lymphoblast |
| Growth Mode: | suspension |
| DNA Profile: | Amelogenin: X,Y CSF1PO: 10 D13S317: 8,11 D16S539: 12 D5S818: 12 D7S820: 10,13 THO1: 9,10 TPOX: 9,11 vWA: 19,20 Our Cell Line Authentication Service |
| Culture Medium: |
RPMI-1640+10%FBS RL完全培養(yǎng)基，# CBP60269M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | CD19 +; CD20 +; CD21 +; CD22 +; Hle-1 +; HLA DQ +; HLA DR +; CD25 -; T cell receptor (TCR) - |
| Genes Expressed: | immunoglobulin; surface IgM and IgD; secreted IgM (low levels) |
| Cellular Products: | immunoglobulin; surface IgM and IgD; secreted IgM (low levels) |
| Comments: | Exposure of RL cells to protein kinase C activating phorbol esters such as PMA and PdBu induced profound growth inhibition. RL cells have been reported to be Epstein-Barr virus genome negative. For more information, please contact us (4008-750-250). |
